InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,178.57
(
-0.18%
)
US TECH 100
17,540.80
(
-0.41%
)
Dow Jones
38,878.81
(
-0.01%
)
Brent Oil
82.47
(
-0.48%
)
Bitcoin
62,230.22
(
-0.17%
)
Post# of 402749
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Blue Fin

Send PM Follow Ignore
Followers 33
Posts 3653
Boards Moderated 0
Alias Born 01/31/2004

Blue Fin

Re: None

Sunday, 12/17/2017 1:29:35 PM

Sunday, December 17, 2017 1:29:35 PM

Post# of 402749
Kevetrin: The primary phase II trial is to determine the effects Kevetrin has regarding p53, designed and requested by BP. Could the BP be Pfizer? If there is a sale I would hope a stock trade would be an option.

http://www.ipharminc.com/new-blog/2016/10/5/cracking-p53a-job-for-ibms-watson-one-might-presume-1
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IPIX News
More IPIX News
InvestorsHub NewsWire

FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

Start posting your company's news
Only $200 per official company press release!